TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-25
DOI
10.1038/s41418-018-0202-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
- (2017) Xuetian Yue et al. JOURNAL OF MOLECULAR BIOLOGY
- GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma
- (2016) S Yuan et al. ONCOGENE
- Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer
- (2016) A Blomme et al. ONCOGENE
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer
- (2015) Karim Fahmy et al. INTERNATIONAL JOURNAL OF CANCER
- Relationship Between Tumor Size and Survival in Non–Small-Cell Lung Cancer (NSCLC): An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry
- (2015) Jianjun Zhang et al. Journal of Thoracic Oncology
- Prognostic Impact of Microscopic Vessel Invasion and Visceral Pleural Invasion in Non–Small Cell Lung Cancer
- (2014) Shinya Neri et al. ANNALS OF SURGERY
- Signaling through C2 domains: More than one lipid target
- (2014) Senena Corbalan-Garcia et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non-Small Cell Lung Cancer
- (2014) M. A. Molina-Vila et al. CLINICAL CANCER RESEARCH
- The role of the ubiquitin-proteasome pathway in cancer development and treatment
- (2014) Fangbao Ding Frontiers in Bioscience-Landmark
- DNA Promoter Methylation-dependent Transcription of the Double C2-like Domain β (DOC2B) Gene Regulates Tumor Growth in Human Cervical Cancer
- (2014) Shama Prasada Kabekkodu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/β-catenin signalling pathway in hepatocellular carcinoma
- (2014) J. Lv et al. JOURNAL OF VIRAL HEPATITIS
- Smoking, p53 Mutation, and Lung Cancer
- (2014) Don L. Gibbons et al. MOLECULAR CANCER RESEARCH
- SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer
- (2014) F Han et al. ONCOGENE
- Large-Cell Neuroendocrine Carcinoma of the Lung
- (2014) Hiroyuki Sakurai et al. Thoracic Surgery Clinics
- Myoferlin Is a Key Regulator of EGFR Activity in Breast Cancer
- (2013) A. Turtoi et al. CANCER RESEARCH
- Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis
- (2013) Yimiao Xu et al. CELLULAR SIGNALLING
- Epigenetic silencing ofAristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer
- (2013) Wen-Bin Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Treatment with curative intent of stage III non-small cell lung cancer patients of 75years: A prospective population-based study
- (2011) Rinus Wanders et al. EUROPEAN JOURNAL OF CANCER
- AP-2β enhances p53-mediated transcription of the αB-crystallin gene through stabilizing p53
- (2011) Xiang Hu et al. MOLECULAR BIOLOGY REPORTS
- Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo
- (2011) Carol Yu et al. VASCULAR PHARMACOLOGY
- Myoferlin is critical for endocytosis in endothelial cells
- (2009) Pascal N. Bernatchez et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Myoferlin is required for insulin-like growth factor response and muscle growth
- (2009) Alexis R. Demonbreun et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started